Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICA-105665 in Epilepsy Patients With Photosensitivity
NCT00979004Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Sep 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ica-105665 in epilepsy, sponsored by Pfizer. Started Sep 2009; status: terminated.
02
Drugs
ica-105665
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00979004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00979004.